行情

BNTC

BNTC

Benitec
NASDAQ

实时行情|Nasdaq Last Sale

4.400
+0.220
+5.27%
休市 16:00 04/09 EDT
开盘
4.670
昨收
4.180
最高
4.670
最低
4.400
成交量
4,955
成交额
--
52周最高
21.80
52周最低
2.760
市值
7,068.48万
市盈率(TTM)
-8.8801
分时
5日
1月
3月
1年
5年

EPS

BNTC 新闻

更多
  • 白俄罗斯总理建议欧亚经济联盟大力推动去美元化进程
  • 央视 · 1小时前
  • 摩根大通大幅下调对美国经济前景的预期
  • 新浪财经综合 · 1小时前
  • 美股战“疫”小记:美股在这个早春都经历了什么?
  • 新浪财经综合 · 1小时前
  • 疫情之下这几家或可跑赢大盘 苹果、亚马逊名列其中
  • 新浪科技综合 · 3小时前

所属板块

生物技术和医学研究
+1.63%
制药与医学研究
+0.82%

热门股票

代码
价格
涨跌幅

BNTC 简况

Benitec Biopharma Limited is a biotechnology company. The Company is engaged in progressing programs through the clinic; the commercialization of its Intellectual Property (IP); development of its therapeutic pipeline and pre-clinical programs, and funding, and protecting and building the IP estate. Its In-house product candidates include TT-034, BB-HB-331, BB-AMD-211 and ddRNAi therapeutic. It is focused on commercialization by licensing and partnering of patents and licenses in biotechnology, in functional genomics, with applications in biomedical research and human therapeutics. It has a pipeline of in-house and partnered therapeutic programs based on its patented gene-silencing technology, deoxyribonucleic acid (DNA)-directed ribonucleic acid interference (ddRNAi). The Company is engaged in developing treatments for chronic human conditions, such as hepatitis B, wet age-related macular degeneration (AMD), and oculopharyngeal muscular dystrophy (OPMD) based on this technology.
展开

微牛提供Benitec Biopharma Ltd(NASDAQ-BNTC)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的BNTC股票新闻,以帮助您做出投资决策。